An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This prospective observational study aims to evaluate safety, application and onset of effect
of rituximab in clinical routine treatment of severe active rheumatoid arthritis during the
first 6 months (in case of re-therapy: 12 months).